Drug Discovery: Overview
Genetic Screens
Structure-Activity Relationships and Drug Design
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Nov 27, 2025

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
Published on: May 16, 2021
Christian Feldmann1, Dimitar Yonchev1, Jürgen Bajorath1
1LIMES Program Unit Chemical Biology and Medicinal Chemistry, Department of Life Science Informatics, B-IT, Rheinische Friedrich-Wilhelms-Universität, Endenicher Allee 19c, D-53115 Bonn, Germany.
This study reveals that chemical structure predicts compound activity across multiple targets. Machine learning models identified distinct structural features that differentiate promiscuous and single-target compounds, aiding drug discovery.
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: